The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia
Stacey Ruiz, Yelena Krupnik, Michael Keating, Joya Chandra, Michael Palladino, David McConkey
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia'. Together they form a unique fingerprint.